Author:
Gupta Ankur,Siddiqui Zaved,Sagar Ganga,Rao Kanury V. S.,Saquib Najmuddin
Abstract
AbstractUntargeted serum metabolomics was combined with machine learning-powered data analytics to develop a test for the concurrent detection of multiple cancers in women. A total of fifteen cancers were tested where the resulting metabolome data was sequentially analysed using two separate algorithms. The first algorithm successfully identified all the cancer-positive samples with an overall accuracy of > 99%. This result was particularly significant given that the samples tested were predominantly from early-stage cancers. Samples identified as cancer-positive were next analysed using a multi-class algorithm, which then enabled accurate discernment of the tissue of origin for the individual samples. Integration of serum metabolomics with appropriate data analytical tools, therefore, provides a powerful screening platform for early-stage cancers.
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Bray, F., Laversanne, M., Weiderpass, E. & Soerjomataram, I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127, 3029–3030 (2021).
2. Fitzmaurice, C. et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: A systematic analysis for the Global Burden of Disease study. JAMA Oncol. 4, 1553–1568 (2018).
3. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
4. World Health Organization. Guide to Early Cancer Diagnosis. https://apps.who.int/iris/bitst ream/handle/10665/254500/9789241511940-eng.pdf?sequence=1&isAllowed=y (2017).
5. Ofman, J.J. & Raza, A. Taking Early Cancer Detection to the Next Level. (Scientific American, 2020).